Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like Clasado To Exhibit At In Las Vegas June 22, 2017 FDA Head Postpones Layoff Notices of Thousands of Employees July 25, 2017 The Best Career Advice from Axovant's CEO October 11, 2017
